Previous close | 494.44 |
Open | 493.35 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 492.52 - 497.78 |
52-week range | 290.87 - 497.78 |
Volume | |
Avg. volume | 2,907 |
Market cap | 127.29B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 0.52 |
EPS (TTM) | 9.48 |
Earnings date | 04 Nov 2024 - 08 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We recently compiled a list of the Jim Cramer’s 10 Go-To Stocks for Success. In this article, we are going to take a look at where Vertex Pharmaceutical Inc. (NASDAQ:VRTX) stands against Jim Cramer’s other go-to stocks for success. In a recent episode of Mad Money, Jim Cramer offers a perspective on Nvidia and its recent […]
As of August 2024, major U.S. stock indexes have experienced declines ahead of Federal Reserve Chair Jerome Powell's anticipated speech, with the S&P 500 and Nasdaq Composite shedding significant points. Despite this volatility, certain stocks may still be trading below their estimated value, presenting potential opportunities for investors. In a market characterized by fluctuating indices and economic resilience, identifying undervalued stocks requires a keen eye for companies with strong...
Texas Instruments, Union Pacific, Vertex Pharmaceuticals, Tile Shop and Gencor are included in this Analyst Blog.